HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical Experience With Once-Daily Dapsone Gel, 7.5% Monotherapy in Patients With Acne Vulgaris.

AbstractBACKGROUND:
Dapsone gel, 7.5% is a topical medication approved for acne in patients aged 12 years and older. Clinical trials have demonstrated the safety and efficacy of once-daily dapsone gel, 7.5% in patients with moderate acne.
OBJECTIVE:
The objective of this report is to describe the clinical course of 8 patients who participated in a 12-week program using once-daily dapsone gel, 7.5% as monotherapy for acne in a real-world clinical setting.
MONOTHERAPY PROGRAM:
Male and female adults and adolescents with facial acne, representing a broad range of ages, skin phototypes, and ethnicities, and with no prior use of dapsone gel, 7.5% applied the product once daily for 12 weeks as monotherapy for acne. Photographs were taken at baseline and at 12 weeks. The treating dermatologists recorded observations of baseline disease, treatment tolerability, and outcomes. An independent rater assessed Global Acne Assessment Score (GAAS) at baseline and at 12 weeks based on photographs. Patients provided testimonials of their experience with treatment.
PROGRAM OUTCOMES:
Acne improvement was evident in the photographs of the 8 patients. Changes in GAAS at week 12 of treatment, as assessed by an independent rater, ranged from 1- to 3-grade improvement from baseline.
CONCLUSION:
Photographs, dermatologist reports, and patient commentary in an office-based practice demonstrated that 12 weeks of treatment with only topical dapsone gel, 7.5%, applied once daily, was effective and well tolerated as a stand-alone treatment in 8 patients with facial acne vulgaris, with results that are consistent with the phase 3 pivotal trials. J Drugs Dermatol. 2018;17(6):602-608.
AuthorsToni C Stockton, Emil A Tanghetti, Edward Lain, Joshua A Zeichner, Nancy Alvandi
JournalJournal of drugs in dermatology : JDD (J Drugs Dermatol) Vol. 17 Issue 6 Pg. 602-608 (Jun 01 2018) ISSN: 1545-9616 [Print] United States
PMID29879247 (Publication Type: Journal Article)
Chemical References
  • Anti-Infective Agents
  • Gels
  • Dapsone
Topics
  • Acne Vulgaris (diagnosis, drug therapy)
  • Administration, Topical
  • Adolescent
  • Adult
  • Anti-Infective Agents (administration & dosage, chemistry)
  • Dapsone (administration & dosage, chemistry)
  • Drug Administration Schedule
  • Drug Compounding
  • Female
  • Gels
  • Humans
  • Male
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: